tirzepatide vs insulin versus glargine as second-line or third-line therapy in type 2 diabetes in the Asia-Pacific region: the SURPASS-AP-Combo trial Semaglutide vs Tirzepatide, which is

I just started my second month

Those conditions include rapid dose escalation of bupropion, concurrent use of medications that lower the seizure threshold, eating disorders with purging behavior, alcohol withdrawal, and critically for our discussion, dehydration and electrolyte imbalances

Before deciding, consult your health care provider to discuss the benefits and drawbacks of each medication

Managing side effects during dose titration Every dose increase brings the possibility of temporary side effects

Tirzepatide shows greater weight loss (16 to 22.5% of body weight) compared to orforglipron (12.4% at a 36 mg dose)